Skip to main content
BELLUSCURA PLC logo

BELLUSCURA PLC — Investor Relations & Filings

Ticker · BELL ISIN · GB00BD3B8Z11 LEI · 213800BRJQZE56XBPW94 IL Manufacturing
Filings indexed 240 across all filing types
Latest filing 2022-07-14 Declaration of Voting R…
Country GB United Kingdom
Listing IL BELL

About BELLUSCURA PLC

https://belluscura.com/

Belluscura PLC is a medical device company specializing in the development and commercialization of advanced oxygen enrichment technologies. The company's primary focus is on manufacturing lightweight, portable oxygen concentrators (POCs) designed to improve the quality of life for individuals requiring supplemental oxygen therapy. Its product portfolio is headlined by the FDA-cleared X-PLOR® and the DISCOV-R™ models. These devices utilize proprietary, patented technologies such as ModulAir™ and an Airgonomical™ design to deliver high oxygen output in a compact form factor, offering an alternative to traditional, cumbersome oxygen tanks and promoting user mobility and independence.

Recent filings

Filing Released Lang Actions
Exercise of Warrants
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is a short announcement released via RNS (Regulatory Information Service) on July 14, 2022. The content explicitly details the 'Exercise of Warrants' resulting in the issuance of new shares and subsequently updates the 'Total voting rights'. This type of corporate action announcement, dealing with capital structure changes (share issuance via warrant exercise) and resulting voting rights, fits best under Capital/Financing Update (CAP) or Share Issue/Capital Change (SHA). Since the primary focus is the issuance of shares following a financing instrument exercise and the resulting change in total shares, SHA is highly relevant. However, the document is a brief regulatory notification (RNS format) announcing a specific corporate event rather than a comprehensive filing. Given the options, 'SHA' (Share Issue/Capital Change) directly describes the core event (issuance of 66,667 shares). Alternatively, since it is a standard regulatory news service release, 'RNS' could be considered, but SHA is more specific to the content. I will classify it as SHA as it details a specific capital change event.
2022-07-14 English
Direct to Consumer Sales and Distribution Plan
Earnings Release Classification · 99% confidence The document is identified by the 'RNS Number : 7145Q' header and contains information disseminated via RNS, the news service of the London Stock Exchange. The content announces a strategic business update: the launch of a Direct to Consumer sales plan and a new Partnership Distributor Plan for their oxygen concentrators. This is a general corporate announcement that does not fit the specific definitions for financial reports (10-K, IR, ER), management changes (MANG), or shareholder actions (DIV, DVA). Since it is a general regulatory announcement that doesn't fit a more specific category, the most appropriate classification is the general Regulatory Filings category (RNS). The document length is short (3949 chars), but it is reporting the news itself, not just announcing the publication of a separate, larger report. H1 2022
2022-06-30 English
Launch of Next Gen X-PLOR Oxygen Concentrator
Regulatory Filings Classification · 99% confidence The document is identified by the header "RNS Number : 2048Q" and concludes with standard boilerplate text from RNS, the news service of the London Stock Exchange, stating that RNS is approved by the Financial Conduct Authority (FCA) to act as a Primary Information Provider. The content announces the 'Launch of Next Generation X-PLOR Portable Oxygen Concentrator' and includes inside information warnings typical of regulatory news services. Since this is a general, time-sensitive announcement distributed via the official regulatory news service (RNS) that doesn't fit neatly into specific categories like ER, DIV, or MANG, it falls under the general regulatory announcement category.
2022-06-27 English
TR-1: Notification of major holdings
Major Shareholding Notification Classification · 99% confidence The document is clearly identified as an 'RNS Number : 8010M' from Belluscura PLC, dated May 25, 2022. The core content is a 'TR-1: Standard form for notification of major holdings'. This form details changes in the percentage of voting rights held by a specific entity (Tekcapital PLC), crossing a threshold (from 15.1348% to 14.1377%). This type of filing, which reports changes in significant share ownership, directly corresponds to the definition for Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2022-05-25 English
TR-1: Notification of major holdings
Major Shareholding Notification Classification · 99% confidence The document is explicitly titled 'TR-1: Standard form for notification of major holdings' and contains fields detailing the 'Identity of the issuer', the 'Reason for the notification' (specifically noting an event changing the breakdown of voting rights), the 'Details of person subject to the notification obligation' (Dowgate Wealth Limited), and the 'Total positions of person(s) subject to the notification obligation' showing a change in percentage of voting rights (from 5.038840% to 4.920000%). This structure is characteristic of regulatory filings concerning changes in significant share ownership thresholds. This directly matches the definition for Major Shareholding Notification (MRQ). Although it is distributed via RNS, the core content is the major holding notification itself, not just an announcement of publication.
2022-05-24 English
Belluscura Expands its Patent Portfolio
Environmental & Social Information Classification · 99% confidence The document is identified by the header 'RNS Number : 0253M' and contains a date (19 May 2022) and company information, typical of a regulatory news service release. The content announces patent issuances related to medical devices, which is corporate news. Crucially, the footer explicitly states: 'Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases such as marketing messages, corporate and product information into the public domain.' It also notes that Reach announcements are distinguished from RNS UK regulatory service. Since this is a non-regulatory corporate announcement (patent expansion) distributed via the Reach service, and it does not fit specific categories like ER, DIV, or MANG, the most appropriate general category for miscellaneous, non-core regulatory news announcements is 'Regulatory Filings' (RNS), as per the provided definitions, which serves as the fallback for filings that do not fit elsewhere, even if it's technically a 'Reach' announcement rather than a mandatory RNS filing.
2022-05-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.